FDA Adverse Event Malfunction Summary report: N

BD BBL¿ CHROMAGAR¿ ORIENT/TSA II W/5% SB

MDR report key: 24053720 · Received January 13, 2026

Report

Report Number
1119779-2025-05559
Event Type
Malfunction
Date Received
January 13, 2026
Date of Event
December 23, 2025
Report Date
February 9, 2026
Manufacturer
BECTON DICKINSON & CO. (SPARKS)
Product Code
JSH
UDI-DI
10382902222399
PMA / PMN Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OR, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED. E1: INITIAL REPORTER ADDITIONAL PHONE # (B)(6).

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS HAVE BEEN UPDATED WITH CORRECTED AND/OR ADDITIONAL INFORMATION. D9: DEVICE AVAILABLE FOR EVALUATION: YES. D9: RETURNED TO MANUFACTURER ON: 24-DEC-2025. INVESTIGATION SUMMARY: DURING MANUFACTURING OF MATERIAL 222239, MEDIA IS FORMULATED AND SENT THROUGH A HIGH TEMPERATURE SHORT TIME STERILIZER TO REMOVE BIOBURDEN. THE PETRI DISHES ARE SUBJECTED TO UV RADIATION TO DECREASE BIOBURDEN. THE PETRI DISHES ARE FILLED IN A POSITIVE PRESSURE HEPA FILTERED ENVIRONMENT. THE FILLED PLATES ARE COOLED AND IMMEDIATELY WRAPPED INTO SLEEVES TO DECREASE THE INTRODUCTION OF MICROBES. SLEEVES ARE THEN PACKAGED INTO CARTONS AND THEN TRANSFERRED TO A REFRIGERATED TRUCK (2 TO 8 DEGREES C) FOR SHIPMENT TO THE DISTRIBUTOR. BD DISTRIBUTORS ARE PROVIDED WITH THE STORAGE GUIDELINES FOR THE SHIPPING AND HANDLING OF BD MEDIA OF 2 TO 8 DEGREES C IN A DARK PLACE. THE BATCH HISTORY RECORD FOR BATCH 5293025 WAS SATISFACTORY AND NO QUALITY NOTIFICATIONS WERE GENERATED DURING MANUFACTURING AND INSPECTION. ALL BATCHES ARE TESTED PRIOR TO RELEASE AND RESULTS REPORTED ON THE CERTIFICATE OF ANALYSIS WHICH CAN BE OBTAINED AT WWW.BD.COM/REGDOCS. MATERIAL 222239 IS STABILITY TESTED BIENNIALLY FOR BIOLOGICAL PERFORMANCE TO ENSURE SATISFACTORY PERFORMANCE THROUGHOUT SHELF LIFE WITH THE ORGANISMS THAT ARE REPORTED ON THE CERTIFICATE OF ANALYSIS. ALL PERFORMANCE TESTING FOR BATCH 5293025 WAS SATISFACTORY AT THE TIME OF RELEASE. NO RETENTION SAMPLES WERE AVAILABLE FOR INVESTIGATION OF THIS COMPLAINT. NO PHOTOS WERE AVAILABLE TO ASSIST WITH THE INVESTIGATION OF THIS COMPLAINT. ONE SEALED SLEEVE (10 PLATES) OF BATCH 5293025 WAS RETURNED TO ASSIST WITH THIS INVESTIGATION. THE RETURNED SAMPLE WAS PERFORMANCE TESTED FOR GROWTH RECOVERY AND REACTION COLOR FOR THE ORGANISMS OUTLINED IN THE COA. THE RESULTS WERE SATISFACTORY PER BD INTERNAL PROCEDURES. THIS COMPLAINT CANNOT BE CONFIRMED FOR NO OR FALSE REACTION. TESTING OF RETURNED SAMPLES PRODUCED SATISFACTORY RESULTS PER INTERNAL PROCEDURES. THE COMPLAINT HISTORY WAS REVIEWED, AND NO COMPLAINT TRENDS FOR THIS DEFECT HAVE BEEN IDENTIFIED FOR THIS PRODUCT; NO ACTIONS ARE INDICATED AT THIS TIME. BD WILL CONTINUE TO TREND COMPLAINTS FOR DEFECTS.

Description of Event or Problem · 0

REPORT 1 OF 2. IT WAS REPORTED THAT WHILE USING ONE BD BBL¿ CHROMAGAR¿ ORIENT/TSA II W/5% SB, THE CUSTOMER NOTICED MEDIUM SIZED, DARK ROSE TO PINK, TRANSPARENT COLONIES THAT WERE ORIGINALLY THOUGHT TO BE E. COLI, BUT MALDI CONFIRMED AS CITROBACTER. THE CITROBACTER WAS RELEASED TO PHYSICIAN BUT WAS LATER CORRECTED TO E. COLI. THERE WAS NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

Description of Event or Problem · 0

REPORT 1 OF 2. IT WAS REPORTED THAT WHILE USING ONE BD BBL¿ CHROMAGAR¿ ORIENT/TSA II W/5% SB, THE CUSTOMER NOTICED MEDIUM SIZED, DARK ROSE TO PINK, TRANSPARENT COLONIES THAT WERE ORIGINALLY THOUGHT TO BE E. COLI, BUT MALDI CONFIRMED AS CITROBACTER. THE CITROBACTER WAS RELEASED TO PHYSICIAN BUT WAS LATER CORRECTED TO E. COLI. THERE WAS NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
116454 BD BBL¿ CHROMAGAR¿ ORIENT/TSA II W/5% SB CULTURE MEDIA, NON-SELECTIVE AND DIFFERENTIAL JSH BECTON DICKINSON & CO. (SPARKS) 5293025 10382902222399

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown